Jubilant Pharmova Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 16,667 million compared to INR 15,847 million a year ago. Revenue was INR 16,902 million compared to INR 16,126 million a year ago. Net income was INR 625 million compared to INR 54 million a year ago. Basic earnings per share from continuing operations was INR 3.94 compared to INR 0.34 a year ago. Diluted earnings per share from continuing operations was INR 3.94 compared to INR 0.34 a year ago.
For the six months, sales was INR 32,332 million compared to INR 30,252 million a year ago. Revenue was INR 32,857 million compared to INR 30,756 million a year ago. Net income was INR 689 million compared to INR 525 million a year ago. Basic earnings per share from continuing operations was INR 4.34 compared to INR 3.3 a year ago. Diluted earnings per share from continuing operations was INR 4.34 compared to INR 3.3 a year ago.